Urboda, Jenny P.

HRN: 29-39-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/27/2026
08/03/2026
IV
600mg
Q8
Diabetic Foot Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: